You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Making Headway in Hepatorenal Syndrome Management

  • Authors: Hugo E. Vargas, MD; Andres Cardenas, MD, MMSc, PhD, AGAF, FAASLD; Kevin P. Moore, MD, PhD
  • CME / ABIM MOC Released: 8/5/2022
  • Valid for credit through: 8/5/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for gastroenterologists, nephrologists, and critical care specialists.

The goals of this activity are that learners will be better able to recognize and diagnose hepatorenal syndrome (HRS) and will have better understanding of advances in treatment of HRS.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Evidence on timing of vasoconstrictor therapy in the management of hepatorenal syndrome with acute kidney injury (HRS-AKI)
    • Recent clinical data on novel therapies for the treatment of decompensated liver disease
  • Have greater competence related to
    • Clinical application of the diagnostic criteria for HRS-AKI
  • Demonstrate greater confidence in their ability to
    • Understand the goals of treatment for HRS-AKI


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Hugo E. Vargas, MD

    Professor of Medicine
    Medical Director, Clinical Trials Office
    Mayo Clinic Arizona
    Phoenix, Arizona

    Disclosures

    Hugo E. Vargas, MD, has the following relevant financial relationships:
    Consultant or advisor for: Mallinckrodt Pharmaceuticals
    Research funding from: Mallinckrodt Pharmaceuticals; Sequana Medical

Speakers

  • Andres Cardenas, MD, MMSc, PhD, AGAF, FAASLD

    Faculty Member & Consultant
    Institute of Digestive Diseases & Metabolism
    Hospital Clinic of Barcelona
    University of Barcelona
    Barcelona, Spain

    Disclosures

    Andres Cardenas, MD, MMSc, PhD, AGAF, FAASLD, has no relevant financial relationships.

  • Kevin P. Moore, MD, PhD

    Professor of Hepatology
    University College London
    Royal Free London Foundation Trust
    London, United Kingdom

    Disclosures

    Kevin P. Moore, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Mallinckrodt Pharmaceuticals
    Speaker or member of speakers bureau for: Mallinckrodt Pharmaceuticals
    Research funding from: Mallinckrodt Pharmaceuticals
    Owns stock (privately owned) in: Salutare Group Ltd.

Editors

  • George Boutsalis, PhD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    George Boutsalis, PhD, has no relevant financial relationships.

  • Asha P. Gupta, PharmD, RPh

    Associate Medical Education Director, Medscape, LLC

    Disclosures

    Asha P. Gupta, PharmD, RPh, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Making Headway in Hepatorenal Syndrome Management

Authors: Hugo E. Vargas, MD; Andres Cardenas, MD, MMSc, PhD, AGAF, FAASLD; Kevin P. Moore, MD, PhDFaculty and Disclosures

CME / ABIM MOC Released: 8/5/2022

Valid for credit through: 8/5/2023

processing....

Educational Impact Challenge

The goals of this activity are that learners will be better able to recognize and diagnose hepatorenal syndrome (HRS) and will have better understanding of advances in treatment of HRS.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.